Inactive Partial Small Business Set-Aside (FAR 19.5)

INTRODUCTION: THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION The National Institutes of Hea... INTRODUCTION: THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION The National Institutes of Health (NIH), Clinical Center (CC), Office of Purchasing and Contracts (OPC) on behalf of the Critical Care Medicine Department, Clinical Center (CC) at the National Institutes of Health (NIH) intends to negotiate and award a contract without providing for full and open competition to Life Technology. NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE The intended procurement is classified under NAICS code 334516 with a Size Standard of 1000 # of Employees. REGULATORY AUTHORITY The resultant contract will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 2005-95, MAY 6, 2020 .This acquisition is conducted under the procedures as prescribed in FAR subpart 13.106-1 Simplified Acquisition Procedures. STATUTORY AUTHORITY This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures, Subpart 13.106-1 (b) (1), Soliciting from a single source and is not expected to exceed the simplified acquisition threshold. Contracts awarded using FAR Part 13-Simplifeid Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. GENERAL INFORMATION 1. Title- Promega GLOMAX INJECTORS EQUIPMENTs 2. Background Information: The Clinical Center at the National Institutes of Health (NIH) in Bethesda, Maryland, is the nation's largest hospital devoted entirely clinical research. It is a national resource that makes it possible to rapidly translate scientific observations and laboratory discoveries into new approaches for diagnosing, treating, and preventing disease. Approximately 1,500 studies are in progress at the NIH Clinical Center. Approximately, half of the studies are the first tests of new drugs or medical treatments in humans. The rest are natural history studies which include many rare diseases. These long-term studies lead to a better understanding of how diseases develop and result in improvements in prevention and treatment. 3. Purpose or Objective: Clinical Center has a clinical support team to address a procurement for the equipment that is already in use to be used together as a system or part of a system. Promega is the only known vendor who is capable of providing the required equipment and system. this equipment is the treatment of infectious diseases for patients at the Critical Care Medicine Department. The equipment support services on Promega is the replacement of the equipment under Perkin Elmer, services and parts of the equipment which is compatible from the previous vendor . 4. Delivery Date: after contract award CONTRACTOR REQUIREMENTS (SCOPE OF WORK) Vendor will provide the required deliverables of equipment to expand its current system capabilities and will seamlessly expand and integrate with existing system, components and equipment to allow the standardize its functionality of the system effectively. CONTRACTING WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION The intended sole source is the only known source to meet the technical needs of the Consultation services. The determination by the Government to award a contract without providing for full and open competition is based upon the market research conducted as prescribed in FAR Part 10-Market Research. CLOSING STATEMENT This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include a technical proposal, a cost-price proposal, the period of performance, the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement. All responses must be received by June 18, 2020 12:00 PM Eastern time and must reference solicitation number 20-010335. Responses may be submitted electronically to Priscilla Abalos Contracting Specialist at Priscilla.abalos@nih.gov Fax responses will not be accepted. "All responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency."

Inactive Partial Small Business Set-Aside (FAR 19.5)

National Institute of HealthNational Clinical Center, Office of Purchasing and Contracts Critical Care Medicine Department 9000 Rockville Pike, Bldg 10/RM 2C145 Bethesda, MD 20892 SOURCES SOUGHT NOTIC... National Institute of HealthNational Clinical Center, Office of Purchasing and Contracts Critical Care Medicine Department 9000 Rockville Pike, Bldg 10/RM 2C145 Bethesda, MD 20892 SOURCES SOUGHT NOTICE Solicitation # HHS-NIH-CC-20-010335 Issued By: Deliver By: NIH Clinical Center June 8, 2020 6707 Democracy Blvd. Suite 106 MSC 5480 Bethesda, MD 20892 Name: Phone Number: Name of Cosignee: Priscilla Abalos 301-594-5918 NIH 9000 Rockville Pike Bethesda, MD 20892 Description: to procure GLOMAX Injectors instrument for evaluating the pathogenesis and treatment of high consequences respiratory viral pathogens samples for current diseases for patients at the clinical center in support of the Critical care Medicine Department. This is a Sources Sought Notice for Commercial Items was conducted in accordance with the format of FAR subpart 12.6. This is NOT a solicitation for proposals, proposal abstracts or quotations. The purpose of this notice is to obtain information regarding the availability and technical capability of the following entities as registered in SAM.gov ( System for award Management). 8(a) Small Business HUBZONE Small Business Small Business Veteran Owned Small Business Women Owned Small Business Background The Critical Care Medicine Department (CCMD) was established in November 1977 to provide medical care for critically ill patients throughout the Clinical Center who have potentially reversible medical problems. Critical care medicine may be defined as the observation, diagnosis, treatment, and rehabilitation of patients with overt or potential failure of vital functions. The Department is currently composed of the following sections Clinical Medical Services Critical Care Therapy and Respiratory Care Research Section AIDS Section Administrative Services CCMD Mission To provide high quality and cost effective clinical service that meets the needs of CC patients and NIH Institutes, to facilitate the research goals of NIH Institutes and investigators, and to conduct high quality research and training in Critical Care Medicine. Requirements: The purpose of this correspondence is the purchase of a Promega GloMax(R) Discover System Fully Loaded with dual injectors. The system will be used to replace a 15 years old unit (Perkin Elmer Victor 3). .Capability Each response should include the following information: Duns Number Company Name Company Address Company Points of Contact: names, titles, addresses, telephone and email addresses Current GSA Schedule appropriate to this Sources Sought Type of Company (i.e., small businesses, 8(a), woman-owned, veteran owned) as validated via the System for Award Management (SAM). All offerors must be registered in the SAM, located at www.sam.gov The Government shall consider all responses received prior to the close date of this procurement on or June 8, 2020 at 12:00 EST. Small Businesses are encouraged to respond if they are able to meet the need of this requirement. Written responses to this notice shall contain sufficient documentation to establish bona fide capability to fulfill the requirement. The proposed award date will be scheduled at a later date. Please email Priscilla Abalos, priscilla.abaloss@nih.gov for questions pertaining to this notice. No phone calls please. Since this a market survey/sources sought, no evaluation letters will be issued to responders. Classification Code: NAICS Code: 334516 Analytical Laboratory Instrument Manufacturing Primary point of contact: Priscilla Abalos Contract Specialist Place of Contract Performance: National Institute of Health, Clinical Center Bethesda, MD 20892